Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy

被引：0
|
作者：
Guttormsen, AB
Ueland, PM
Lonning, PE
Mella, O
Refsum, H
机构：
[1] Univ Bergen, Dept Pharmacol, N-5021 Bergen, Norway
[2] Haukeland Univ Hosp, Dept Oncol, N-5021 Bergen, Norway
来源：
CLINICAL CHEMISTRY | 1998年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1987 / 1989
页数：3
相关论文
共 50 条
  • [1] Calcium Channel Blockers Possibly Delay the Elimination of Plasma Methotrexate in Patients Receiving High-Dose Methotrexate Therapy
    Inose, Ryo
    Takahashi, Katsuyuki
    Nanno, Satoru
    Hino, Masayuki
    Nagayama, Katsuya
    [J]. JOURNAL OF CHEMOTHERAPY, 2019, 31 (01) : 30 - 34
  • [2] Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation
    Koyama, K
    Usami, T
    Takeuchi, O
    Morozumi, K
    Kimura, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (05) : 916 - 922
  • [3] Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC-MS/MS in patients receiving high-dose methotrexate therapy
    Mei, Shenghui
    Shi, Xiaoxu
    Du, Yaming
    Cui, Yong
    Zeng, Chun
    Ren, Xiaohui
    Yu, Kefu
    Zhao, Zhigang
    Lin, Song
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 158 : 300 - 306
  • [4] Homocysteine plasma levels in patients treated with high-dose methotrexate for osteosarcoma. pilot study
    Peyriere, H.
    Badiou, S.
    Mathieu, O.
    Margueritte, G.
    Cociglio, M.
    Vallat, C.
    Cristol, J. P.
    Hillaire-Buys, D.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 35 - 35
  • [5] CHANGES IN PLASMA METHIONINE AND TOTAL HOMOCYSTEINE LEVELS IN PATIENTS RECEIVING METHOTREXATE INFUSIONS
    BROXSON, EH
    STORK, LC
    ALLEN, RH
    STABLER, SP
    KOLHOUSE, JF
    [J]. CANCER RESEARCH, 1989, 49 (21) : 5879 - 5883
  • [6] ACETAZOLAMIDE FOR ALKALINIZATION OF URINE IN PATIENTS RECEIVING HIGH-DOSE METHOTREXATE
    SHAMASH, J
    EARL, H
    SOUHAMI, R
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (02) : 150 - 151
  • [7] KINETICS OF 7-HYDROXY-METHOTREXATE AFTER HIGH-DOSE METHOTREXATE THERAPY
    ERTTMANN, R
    BIELACK, S
    LANDBECK, G
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 101 - 104
  • [8] HIGH-DOSE METHOTREXATE THERAPY
    BELL, R
    SULLIVAN, JR
    MOON, WJ
    HURLEY, TH
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1977, 1 (08) : 247 - 249
  • [9] RISK FACTORS OF DELAYED METHOTREXATE ELIMINATION AFTER RECEIVING HIGH-DOSE METHOTREXATE THERAPY
    Liang, C. A.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S191 - S191
  • [10] PROTEIN-METHOTREXATE-IGG COMPLEXES IN THE SERUM OF PATIENTS RECEIVING HIGH-DOSE ANTIFOLATE THERAPY
    DACOSTA, M
    ISACOFF, W
    ROTHENBERG, SP
    IQBAL, MP
    [J]. CANCER, 1980, 46 (03) : 471 - 474
12345